SASamaneh Arab

Samaneh Arab

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samaneh Arab has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ionotropic Gelation Synthesis of Berberine-Loaded Alginate Nanoparticles: Physicochemical Characterization and Multifunctional Biological Activities

    by Mohadeseh Arabhalvaei, Marjan Bahraminasab, Zahra Nazemi, Samaneh Arab, Akram Alizadeh, Mohammad Sadegh Nourbakhsh

    Background and Aim: Nanoparticle (NP)‑ formulated drug delivery platforms can enhance therapeutic efficacy and bioavailability while reducing limitations such as poor drug solubility and systemic side effects. This study focuses on the synthesis and characterization of berberine (BBR)-loaded sodium alginate (SA) NPs and evaluates their biological activities as a controlled drug delivery platform.Methods: BBR-loaded SA NPs were prepared and characterized for particle size, zeta potential, morphology, FTIR profile, entrapment efficiency, loading capacity, and drug release. Cytotoxicity was assessed in MC3T3‑E1 pre‑osteoblast cells, and cellular uptake was examined by FE‑SEM. Osteogenic differentiation was evaluated using alkaline phosphatase (ALP) and alizarin red assays. Anti‑inflammatory, anticancer, and antibacterial activities were also investigated.Results: FTIR confirmed successful BBR incorporation into SA NPs. These NPs had a size of 183.9 ± 74.17 nm by FE-SEM, zeta potential of -21.47±0.25 mV, entrapment efficiency of 91.8±0.4%, and loading capacity of 19.6±0.1%. A sustained release profile of ~10% over 14 days was observed, along with cellular uptake. The formulation exhibited no observable cytotoxicity at 1.25–2560 µg/mL (viability of > 70%). At 640 µg/mL, the NPs caused the highest ALP activity, mineralization, and cancer cell death. The concentration of 640 µg/mL showed the greatest increase in ALP activity, mineralization, and cancer cell death. The concentrations of 640 and 1280 µg/mL showed anti-inflammatory effect. Antibacterial activity was slight and moderate, respectively, against Pseudomonas aeruginosa (< 20%) and Staphylococcus aureus (< 60%).Conclusion: BBR-loaded SA NPs showed biocompatibility, sustained release, osteogenic potential, and promising anti-inflammatory and anticancer activities.

  • Exploring the anticancer potential of epigallocatechin gallate-loaded sodium alginate nanoparticles: impact of size variation on head and neck cancer cells

    by Faezeh Rajabzadeh, Mohadeseh Arabhalvaei, Samaneh Arab, Elham Sadat Afraz, Marjan Bahraminasab

    Introduction Head and neck cancer is a common malignancy, and its current treatments face major challenges, including recurrence, drug resistance, side effects, and high costs. Epigallocatechin gallate (EGCG) from green tea has anticancer properties, but its low stability and bioavailability limit its clinical use. These limitations may be addressed by nanocarrier-based delivery systems. Methods Five different sizes of sodium alginate (SA) nanoparticles (NPs) were synthesized, and EGCG was loaded into the selected particles. Characterizations of SA NPs with and without EGCG were conducted using dynamic light scattering (DLS), field emission scanning electron microscopy (FE-SEM), and Fourier transform infrared spectroscopy (FTIR). Furthermore, loading capacity, entrapment efficiency, and release profile of the EGCG-loaded NPs were evaluated. The cytotoxicity and cell viability were assessed (MTT and LDH) on TSCC-1 cancer cells. Moreover, cellular uptake, wound healing, colony formation, and apoptosis were also tested. Results The characterizations of NPs confirmed the successful synthesis of SA NPs. Two NP sizes (type 1 and type 4) were selected for EGCG loading, for which the drug release was around 39% for type 1 and 51% for type 4 NPs after 14 days. The optimal cytotoxicity on cancer cells was observed at a concentration of 80 µg/mL of NPs (type 1). A significant reduction in colony numbers was observed after treatment with these EGCG-loaded NPs compared to controls. Furthermore, the EGCG-loaded NPs could prevent cancer cell migration, with an increase in apoptosis levels in TSCC-1 cells treated with type 1 NPs (80 µg/mL). Conclusion It was demonstrated that EGCG-loaded SA NPs effectively inhibit the proliferation and migration and induce apoptosis in head and neck cancer cells. Graphical abstract

  • In vitro anticancer effect of epigallocatechin gallate nano-emulsion on head and neck cancers

    by Zahra Khatib Zadeh, Samaneh Arab, Sohrab Kazemi, Mohadeseh Arabhalvaei, Elham Sadat Afraz, Marjan Bahraminasab

    Head and neck cancer, as one of the most common cancers, causes the death of many people worldwide every year. The current approaches to treat this cancer have not been successful, and recurrence, drug-resistance development, side effects, and high treatment costs are important problems necessitating the need for more effective drugs and treatment approaches. Epigallocatechin gallate (EGCG) is the most plentiful and biological-active catechin in green tea with proved anticancer effect. However, the stability, low bioavailability, and short half-life, limits its clinical use. Nanocarrier development may overcome these deficiencies by improving pharmacokinetics and pharmacodynamics. Therefore, this study aimed to examine the nano-emulsion containing EGCG for their anticancer activity. First, EGCG nano-emulsion was prepared, which was then characterized by dynamic light scattering (DLS), zeta potential, and Fourier transform infrared spectroscopy (FTIR). The toxicity of the nano-emulsion on the TSCC-1 cancer cell line was assessed by MTT and LDH assays. Cell migration rate, colony-formation ability, the apoptosis rate, and the expression level of BAX, BCL2, and VEGF genes after treatment of cancer cells were assessed. Moreover, the effect of EGCG nano-emulsion on the spheroid growth of TSCC-1 cells in three-dimensional (3D) culture was investigated. The FTIR results demonstrated the presence of EGCG in the nano-emulsion. The size and zeta potential of the nano-emulsion with and without EGCG were 17.53 ± 1.62 nm and − 0.166 ± 0.169 mV, and 14.0 ± 2.3 nm and − 0.266 ± 0.169 mV, respectively. The sustained drug release was observed. Moreover, the MTT assay exhibited that the cytotoxicity of the nano-emulsion was significant at a concentration of 80 µg/mL on TSCC-1 cells. The colony-formation assay revealed no colonies in the groups treated with nano-emulsion containing EGCG compared to the control group. The scratch test also showed the ability of nano-emulsion to inhibit cell migration. Furthermore, the induction of delayed apoptosis by 88.3 ± 3.18% was observed in the group treated with EGCG nano-emulsion at a concentration of 80 µg/mL. The expression of BCL2 and VEGF genes significantly decreased, while that of BAX gene increased. Moreover, the 3D culture showed a decrease in the size and growth of spheroids in the EGCG nano-emulsion-treated group compared to the control group. The results showed that the nano-emulsion containing EGCG has significant anticancer activity (TSCC-1) and may be a suitable treatment option for the management of squamous cell carcinoma of the head and neck. Graphical abstract


  • Open Access

    Critical-size bone defect repair with three types of nano-hydroxyapatite scaffolds: An in vivo study

    by Mohammad Yousefi, Mohammad Yousefi, Mohammad Yousefi, Nicola Maffulli, Nicola Maffulli, Nicola Maffulli, Marjan Bahraminasab, Marjan Bahraminasab, Marjan Bahraminasab, Samaneh Arab, et al.

    Introduction: Hydroxyapatite (HA), the main mineral component of bone, can be synthesized and utilized in the bone lesion treatments because of its high bioactivity and osteoconductive property. HA extraction from fish bones has received special attention given its low cost and easier extraction protocol compared to other sources. The present study compared the biocompatibility and bone repair of commercial nano hydroxyapatite (nHA) powder with that extracted from carp and human bones in vitro and in vivo. Methods: First, nHA powders were prepared, and their physical and structural properties were studied using XRD, FTIR, FE-SEM and EDS analyses. Next, the powders were used to make porous scaffolds for which the physicochemical, structural, mechanical and biological properties were evaluated. The in vitro biocompatibility and osteogenic differentiation were tested on MC3T3-E1 cells, respectively, by MTT assay in three time periods and Alizarin red staining. Furthermore, the scaffolds were implanted after creation of critical-size lesions in the skulls of female rats, and the histological investigation was conducted by H&E staining at two time points. Results: The morphological and phase analyses showed the successful fabrication of porous nHA scaffolds with 60.68%, 61.38, and 63.27% for carp, human and commercial nHA scaffolds, respectively. The scaffolds showed different biodegradability behavior where the human nHA scaffolds degrade more rapidly. The results of mechanical tests indicated that the scaffolds made up of human extracted nHA powder had the lowest strength and stiffness (3.13 and 37.37 KPa, respectively). The strength and stiffness of the scaffolds fabricated by carp extracted and commercial nHA were 17.14 and 19.01 Kpa, and 251.79 and 140.49 Kpa, respectively. The MTT test results showed that the greatest cell viability rate was in the carp nHA scaffolds after 10 days (146.08%). Moreover, the AR staining indicated the formation of mineralized nodules caused by the scaffolds in all groups. However, the mineralization seemed to be superior in human, and carp extracted groups. Furthermore, in vivo in all three groups bone repair occurred at the critical-size lesion sites, while scaffolds biodegradation was also observed. The scaffolds made up of carp and human nHA exhibited the highest rate of ossification and maturation of bone tissue among different scaffolds after 8 weeks. The rate of tissue response to these scaffolds was higher than the scaffolds made of commercial nHA after 4 and 8 weeks, postoperatively. Conclusion: The carp extracted nHA scaffolds perform comparable to human extracted nHA, and may be used for clinical applications.


  • Open Access

    Exploring the Anticancer Potential of Epigallocatechin Gallate Loaded Sodium Alginate Nanoparticles: Impact of Size Variation on Head and Neck Cancer Cells

    by Faezeh Rajabzadeh, Mohadeseh Arabhalvaei, Samaneh Arab, Elham Sadat Afraz, Marjan Bahraminasab

    Head and neck cancers, particularly squamous cell carcinomas, are challenging to treat due to recurrence, drug resistance, and side effects. The present study explores using epigallocatechin gallate (EGCG), an anti-cancer compound from green tea, encapsulated in sodium alginate nanoparticles (SA NPs) of varying sizes. Five different sizes of SA NPs were synthesized, and EGCG was loaded into the selected particles. Characterizations of SA NPs with and without EGCG were conducted using dynamic light scattering (DLS), FE-SEM, and Fourier transform infrared spectroscopy (FTIR). Furthermore, the loading capacity, entrapment efficiency and release profile of the EGCG-loaded NPs were evaluated. The cytotoxicity and cell viability were assessed using MTT and LDH assays on TSCC-1 cancer cells. Moreover, cellular uptake, wound healing, colony formation and apoptosis were also tested. The results of characterizations confirmed the successful synthesis of SA NPs. Two NP sizes (type 1 and type 4) were selected for EGCG loading, for which the drug release was around 39% for type 1 and 51% for type 4 nanoparticles after 14 days. The optimal cytotoxicity on cancer cells was observed at a concentration of 80 µg/mL of NPs (type 1). The colony formation analysis displayed a significant reduction in colony numbers after treatment with EGCG-loaded NPs compared to controls. Furthermore, wound healing assays showed the ability of EGCG-loaded NPs to prevent cancer cell migration, and the evaluation of apoptosis demonstrated an obvious increase in apoptosis levels in TSCC-1 cells treated with type 1 NPs (80 µg/mL). It was demonstrated that EGCG-loaded SA NPs effectively inhibit the proliferation and migration, and induce apoptosis in head and neck cancer cells.


  • Open Access

    Development of a hydrogel-based three-dimensional (3D) glioblastoma cell lines culture as a model system for CD73 inhibitor response study

    by Marjan Bahraminasab, Samira Asgharzade, Ali Doostmohamadi, Atefeh Satari, Farkhonde Hasannejad, Samaneh Arab

    Despite the development of various therapeutic approaches over the past decades, the treatment of glioblastoma multiforme (GBM) remains a major challenge. The extracellular adenosine-generating enzyme, CD73, is involved in the pathogenesis and progression of GBM, and targeting CD73 may represent a novel approach to treat this cancer. In this study, three-dimensional culture systems based on three hydrogel compositions were characterized and an optimal type was selected to simulate the GBM microenvironment. In addition, the effect of a CD73 inhibitor on GBM cell aggregates and spheroids was investigated as a potential therapeutic approach for this disease. Rheology measurements, Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM) and cell proliferation assays were performed to analyze the synthesized hydrogel and select an optimal formulation. The viability of tumor cells in the optimal hydrogel was examined histologically and by confocal microscopy. In addition, the sensitivity of the tumor cells to the CD73 inhibitor was investigated using a cell proliferation assay and real-time PCR. The data showed that the hydrogel containing 5 wt% gelatin and 5 wt% sodium alginate had better rheological properties and higher cell viability. Therefore, it could provide a more suitable environment for GBM cells and better mimic the natural microenvironment. GBM cells treated with CD73 inhibitors significantly decreased the proliferation rate and expression of VEGF and HIF1-α in the optimal hydrogel. Our current research demonstrates the great potential of CD73 inhibitor for clinical translation of cancer studies by analyzing the behavior and function of 3D tumor cells, and thus for more effective treatment protocols for GBM.


  • Open Access

    Clinical Characteristics and Prognosis in Allergic Health Workers Patients with COVID-19 Infection

    by Samaneh Arab, Seyed Ali Seyedinia, Raheleh Shokouhi Shoormasti, Parnia Tarahomi, Fatemeh Paknazar, Farhad Malek, Samira Asgharzade, Akram Alizadeh

    Background: After a case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, at the end of 2019, the cause of coronavirus disease 2019 (COVID-19) was soon recognized as a global public health emergency. Objectives: This study aimed to investigate the clinical characteristics of allergic healthcare workers (HCWs) confirmed to have COVID-19. Methods: This study included 30 HCWs with confirmed COVID-19 at Kosar Hospital in Semnan, Iran, from February to June 2020 (15 allergic and 15 non-allergic individuals). Demographic data, clinical manifestations, and laboratory findings of the subjects were recorded. Results: Total IgE, allergen-specific IgE, and anti-SARS-CoV IgG were measured in the patients' serum. The average age of the allergic and non-allergic HCWs with COVID-19 was 33 years, and 80% were female. Malaise (76.6%), fever (60%), weakness (60%), and dry cough (56.7%) were the most common symptoms. The clinical findings showed a significantly lower percentage (33.3%) of dry cough in subjects with allergic diseases. Apart from the observed difference in the mean value of total IgE between the two groups, no significant differences were found with respect to age, duration of disease, O2 saturation, and anti-SARS-CoV-2 IgG. Conclusions: Coronavirus disease 2019 symptoms did not become severe in patients with atopic diseases. Moreover, dry cough and weakness were reported by a lower percentage of allergic HCWs.

  • A thermosensitive hydrogel for the sustained delivery of exosomes extracted from menstrual blood mesenchymal stem cells and frizzled antibody on triple-negative breast cancer cells in vitro

    by Farkhonde Hasannejad, Marjan Bahraminasab, Leila Farahmand, Behrad Darvishi, Vajihe Taghdiri Nooshabadi, Houman Parsaei, Malihe Salehi, Neda Jalili, Mohammad Amin Javidi, Mohadeseh Shayeghan, et al.


  • Open Access

    Effects of Three Retrograde Filling Materials on Production of Inflammatory Cytokines and Resorbing Mediators

    by Samaneh Arab, Marjan Bahraminasab, Masoumeh Motamedi, Jamshid Hadjati, Alaviye Vahid

    : Root-end filling materials are typically used following endodontic surgeries, and due to their different chemical compositions, they have varying effects on the survival and differentiation of tissues around the root apex. The purpose of this in vitro study was to evaluate the effects of three retrograde filling materials—ProRoot MTA, Super ethoxy benzoic acid (EBA), and Geristore—on the production of pro-inflammatory and resorptive cytokines (RANK, RANK-L, OPG, IL-1β, and TNF-α). After mixing and setting, the experimental materials were exposed to UV rays and then applied to the prepared cells. This study used osteoblast (MG-63) and THP-1 monocyte cell lines, as well as peripheral blood monocytes (PBM). The evaluation times for RANK-L and OPG were 24 and 48 hours, while IL-1β and tumor necrosis factor (TNF-α) were evaluated at 24 hours. The RANK levels were measured using flow cytometry, and monocyte survival was assessed at different times using the MTT assay. The results were analyzed using Minitab statistical software, which indicated that the type of material significantly affected cytokine production. Exposure of monocytes to EBA resulted in a decrease in TNF-α and IL-1β secretion compared to the other groups. However, in the THP-1 cell line, there was no significant difference in the release of pro-inflammatory cytokines between the groups. Conversely, Geristore induced the highest level of RANK-L and the lowest level of OPG in cultures with the MG-63 cell line. According to the MTT assay, the viability order of the materials from early to late was Geristore < EBA < MTA.

  • Design and synthesis of berberine loaded nano-hydroxyapatite/gelatin scaffold for bone cancer treatment

    by Sajjad Khajavi, Marjan Bahraminasab, Samaneh Arab, Athar Talebi, Parviz Kokhaei, Hassan Abdoos

    A tissue engineered BBR-loaded nano-HA/gelatin scaffold, as a local drug delivery system, was developed with the aim to be implanted after surgery for osteosarcoma treatment, mimicking the natural tissue ECM, and releasing BBR as an anticancer drug.